Aficamten vs Metoprolol Monotherapy in Obstructive Hypertrophic Cardiomyopathy According to Pretrial Treatment in MAPLE-HCM

Cytokinetics Incorporated published this content on August 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 29, 2026 at 14:48 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]